---
figid: PMC9019764__etm-23-05-11287-g06
pmcid: PMC9019764
image_filename: etm-23-05-11287-g06.jpg
figure_link: /pmc/articles/PMC9019764/figure/f7-ETM-23-5-11287/
number: Figure 7
figure_title: ''
caption: Schematic diagram summarizing the signaling pathway by which SIN inhibits
  liver cancer angiogenesis. SIN represses VEGF expression by downregulating HIF-1Î±
  expression. SIN inhibits VEGF-induced VEGFR2 phosphorylation and sequentially inhibits
  the levels of p-AKT leading to inhibition of EC proliferation, migration, tube formation
  and angiogenesis. SIN, sinensetin; VEGF, vascular endothelial growth factor; HIF,
  hypoxia-inducible factors; VEGFR, vascular endothelial growth factor receptor; EC,
  endothelial cell; p, phosphorylated.
article_title: Sinensetin suppresses angiogenesis in liver cancer by targeting the
  VEGF/VEGFR2/AKT signaling pathway.
citation: Xiao Li, et al. Exp Ther Med. 2022 May;23(5):360.
year: '2022'

doi: 10.3892/etm.2022.11287
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- sinensetin
- angiogenesis
- liver cancer
- human umbilical vascular endothelial cell
- molecular mechanism

---
